{"id":225088,"date":"2026-09-01T09:59:47","date_gmt":"2026-09-01T04:29:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=225088"},"modified":"2026-09-01T09:59:47","modified_gmt":"2026-09-01T04:29:47","slug":"why-ajanta-pharma-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/","title":{"rendered":"Ajanta Pharma (AJANTPHARM) Share Price Falls 3.02% Today: Price Action, Valuation and Peer Analysis"},"content":{"rendered":"<p style=\"margin-top:0!important;\">Ajanta Pharma Share Price fell to Rs 3,510.95 on 01 September 2026, down 3.02% or Rs 109.25 from the previous close of Rs 3,620.20. At the same snapshot, the company\u2019s market capitalisation stood at Rs 44,472.92 crore, keeping the Large Cap pharmaceutical stock in focus on market screens.<\/p>\n<p>The stock opened at Rs 3,603.30, which also marked the day\u2019s high, and later declined to an intraday low of Rs 3,488.40. That pattern shows weakness developed after the open rather than through an early rebound. The supplied dataset confirms the price move, but it does not identify a company-specific trigger for the fall.<\/p>\n<p>Even with the day\u2019s decline, the company continues to trade at a P\/E ratio of 39.86 and a P\/B ratio of 9.31, while profitability metrics remain strong with ROE at 25.42% and ROCE at 32.67%. That combination of premium valuation and solid return ratios is why investors may look beyond the single-session move and compare the stock with its industry context and listed peers.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#Ajanta_Pharma_AJANTPHARM_Share_Price_Today_Price_Action_Analysis\" title=\"Ajanta Pharma (AJANTPHARM) Share Price Today: Price Action Analysis\">Ajanta Pharma (AJANTPHARM) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#Ajanta_Pharma_AJANTPHARM_Fundamental_Analysis\" title=\"Ajanta Pharma (AJANTPHARM) Fundamental Analysis\">Ajanta Pharma (AJANTPHARM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Ajanta_Pharma\" title=\"Why Investors Are Watching Ajanta Pharma\">Why Investors Are Watching Ajanta Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#About_Ajanta_Pharma\" title=\"About Ajanta Pharma\">About Ajanta Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#Track_Ajanta_Pharma_Share_Price_on_Univest\" title=\"Track Ajanta Pharma Share Price on Univest\">Track Ajanta Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#Why_is_Ajanta_Pharma_Share_Price_falling_today\" title=\"Why is Ajanta Pharma Share Price falling today?\">Why is Ajanta Pharma Share Price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#What_is_Ajanta_Pharma_Share_Price_today\" title=\"What is Ajanta Pharma Share Price today?\">What is Ajanta Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#What_does_its_valuation_look_like\" title=\"What does its valuation look like?\">What does its valuation look like?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#How_profitable_is_Ajanta_Pharma_compared_with_its_industry\" title=\"How profitable is Ajanta Pharma compared with its industry?\">How profitable is Ajanta Pharma compared with its industry?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#How_does_Ajanta_Pharma_compare_with_key_pharma_peers\" title=\"How does Ajanta Pharma compare with key pharma peers?\">How does Ajanta Pharma compare with key pharma peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-ajanta-pharma-share-price-fall-today-2026\/#What_should_investors_monitor_next\" title=\"What should investors monitor next?\">What should investors monitor next?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Ajanta_Pharma_AJANTPHARM_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Ajanta Pharma (AJANTPHARM) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,510.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,620.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 109.25 (-3.02%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,603.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,603.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,488.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.43 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,472.92 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ajanta Pharma Share Price moved from Rs 3,620.20 in the previous session to Rs 3,510.95 in today\u2019s snapshot, a fall of Rs 109.25. The stock started at Rs 3,603.30 and could not move above that level during the session, indicating sellers had the upper hand after the open. The subsequent slide to Rs 3,488.40 shows that intraday pressure extended well below both the opening price and the prior close.<\/p>\n<p>Turnover at the time of the dataset stood at Rs 0.43 crore. While turnover alone does not explain the move, it helps place the session in context alongside the intraday range. For traders and short-term watchers, the notable levels from the supplied data are the open and high at Rs 3,603.30, the low at Rs 3,488.40, and the current traded price of Rs 3,510.95.<\/p>\n<p>Because no verified company-specific catalyst is supplied, the day\u2019s move is best read as a factual price event rather than a conclusion about business performance. That is why the next step is to evaluate the stock\u2019s underlying metrics and compare them with its industry and peer set.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ajanta_Pharma_AJANTPHARM_Fundamental_Analysis\"><\/span><strong>Ajanta Pharma (AJANTPHARM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,472.92 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.42%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.67%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 90.82<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 388.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.77%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The company\u2019s fundamentals show a business with strong profitability metrics. ROE stands at 25.42% and ROCE at 32.67%, both robust in absolute terms. EPS is Rs 90.82, while book value per share is Rs 388.77. Dividend yield is 0.77% based on the supplied data.<\/p>\n<p>Valuation, however, remains on the richer side. The stock trades at 39.86 times earnings and 9.31 times book value. Those figures do not automatically indicate overvaluation or undervaluation, but they do show that the market is placing a meaningful premium on the company relative to many businesses in the same industry.<\/p>\n<p>That makes today\u2019s fall notable. It is not occurring in a low-return business based on the available data. Instead, the move is taking place in a company that combines strong return ratios with elevated valuation multiples, a mix that often keeps investor attention focused on both quality and price discipline.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.87x to 667.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.34x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.42%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.81%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.67%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,472.92 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 683.05 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,252.9 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Ajanta Pharma belongs to Healthcare and the Pharmaceuticals &amp; Drugs industry. The supplied benchmark covers 200 companies in the same industry, offering a broad comparison set for valuation, profitability, and size.<\/p>\n<p>On valuation, the company\u2019s P\/E of 39.86 is above the industry median of 30.92 but below the average of 48.02. Its P\/B of 9.31 is well above both the median of 2.88 and the average of 4.34. In simple terms, the stock is priced above typical industry levels on both earnings and book-value multiples.<\/p>\n<p>Profitability tells a different story. ROE of 25.42% is materially higher than the industry median of 11.81% and average of 11.21%. ROCE of 32.67% is also far above the industry median of 13.65% and average of 13.76%. In market-cap terms, the company\u2019s Rs 44,472.92 crore value is much larger than the industry median of Rs 683.05 crore and above the average of Rs 14,252.90 crore. This combination helps explain why the stock can command stronger attention even on a weak trading day.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,60,696.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,062.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,91,515.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,403.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Against the selected peer set, Ajanta Pharma is smaller by market value than Sun Pharmaceutical Industries, Divi\u2019s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, and Cipla. That places it below these major reference names on size, though it still remains a sizeable listed pharma company.<\/p>\n<p>Its P\/E of 39.86 is close to Sun Pharma\u2019s 38.80, above Zydus Lifesciences at 25.69 and Cipla at 33.94, and well below Divi\u2019s at 83.91 and Torrent at 86.82. Its P\/B of 9.31 is higher than Sun Pharma, Zydus Lifesciences and Cipla, but lower than Divi\u2019s and Torrent Pharmaceuticals.<\/p>\n<p>Where Ajanta Pharma compares especially well is profitability. ROE of 25.42% is above Sun Pharma, Divi\u2019s, Zydus Lifesciences and Cipla, while slightly below Torrent\u2019s 26.76%. ROCE of 32.67% is stronger than all five peers listed in the comparison table. That helps explain why the stock can trade at a premium even though it is smaller than the biggest names in the space.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Ajanta_Pharma\"><\/span><strong>Why Investors Are Watching Ajanta Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Ajanta Pharma Share Price declined 3.02% today to Rs 3,510.95 from Rs 3,620.20.<\/li>\n<li>The stock opened at Rs 3,603.30, which was also the day\u2019s high, and later slipped to Rs 3,488.40.<\/li>\n<li>Valuation remains above industry medians, with P\/E at 39.86 and P\/B at 9.31.<\/li>\n<li>ROE of 25.42% and ROCE of 32.67% are both ahead of industry averages.<\/li>\n<li>The company\u2019s Rs 44,472.92 crore market cap keeps it relevant within Healthcare and Pharmaceuticals &amp; Drugs tracking.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Ajanta_Pharma\"><\/span><strong>About Ajanta Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ajanta Pharma operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. Based on the supplied market-cap data, it is substantially larger than the average company in its industry universe.<\/p>\n<p>From a market-analysis perspective, the stock currently stands out for its mix of premium valuation and strong capital-efficiency metrics. That makes the current decline noteworthy, but not enough on its own to establish a broader conclusion without additional company-specific information.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Ajanta_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Ajanta Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma (AJANTPHARM) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a>to review live stock data, top decliners and related market analysis.<\/p>\n<p>Investors tracking Ajanta Pharma Share Price can use Univest to follow live price moves, valuation ratios, peer comparison and broader market context in one place.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Ajanta_Pharma_Share_Price_falling_today\"><\/span><strong>Why is Ajanta Pharma Share Price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The stock is down 3.02% today, falling Rs 109.25 from Rs 3,620.20 to Rs 3,510.95. The supplied data confirms the decline and intraday weakness, but it does not identify a company-specific catalyst behind the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Ajanta_Pharma_Share_Price_today\"><\/span><strong>What is Ajanta Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Ajanta Pharma Share Price today is Rs 3,510.95 at the supplied snapshot time. That is below the previous close of Rs 3,620.20. The previous close was Rs 3,620.2. The stock moved 3.02% lower during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_its_valuation_look_like\"><\/span><strong>What does its valuation look like?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The stock trades at a P\/E ratio of 39.86 and a P\/B ratio of 9.31. Both are above the industry medians of 30.92 and 2.88 respectively. The company trades at a P\/E ratio of 39.86x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Ajanta_Pharma_compared_with_its_industry\"><\/span><strong>How profitable is Ajanta Pharma compared with its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;ROE is 25.42% and ROCE is 32.67%, both well above the Pharmaceuticals &amp; Drugs industry medians of 11.81% and 13.65%. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals &amp; Drugs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Ajanta_Pharma_compare_with_key_pharma_peers\"><\/span><strong>How does Ajanta Pharma compare with key pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Its P\/E is close to Sun Pharma\u2019s, below Divi\u2019s and Torrent, and above Zydus Lifesciences and Cipla. Its ROCE of 32.67% is stronger than all five peers in the supplied comparison set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next\"><\/span><strong>What should investors monitor next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Investors can monitor whether the stock holds above the day\u2019s low of Rs 3,488.40, how its premium valuation compares with peers, and whether strong ROE and ROCE continue to support market positioning.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ajanta Pharma Share Price falls to Rs 3,510.95. marking a 3.02% fall today. Market cap stands at Rs 44,472.92 crore.<\/p>\n","protected":false},"author":29,"featured_media":225086,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-225088","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["225086"],"rank_math_title":["Ajanta Pharma Share Price Today: Price Fall and Valuation"],"rank_math_description":["Ajanta Pharma Share Price falls 3.02% to Rs 3,510.95. Read price action, valuation, profitability, sector benchmark and peer analysis in detail."],"rank_math_focus_keyword":["Ajanta Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Ajanta_Pharma_AJANTPHARM_Share_Price_Falls_302_Today_Price_Action_Valuation_and_Peer_Analysis_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=225088"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225088\/revisions"}],"predecessor-version":[{"id":225089,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225088\/revisions\/225089"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/225086"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=225088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=225088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=225088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}